To provide a test method for a prognosis for cerebral infarction in a subject, and prediction or diagnosis of asymptomatic cerebral infarction or risk of cerebral infarction after a transient ischemic attack, and a kit used for the test method.SOLUTION: A test method comprising a step for measuring the number of SSEA-3-positive pluripotent stem cells in a blood sample collected from a subject, and provides a prognosis for cerebral infarction in the subject, and prediction or diagnosis of asymptomatic cerebral infarction or risk of cerebral infarction after a transient ischemic attack, using the number of pluripotent stem cells as an index, is provided.SELECTED DRAWING: None
MOBILIZATION OF PLURIPOTENT STEM CELLS FOR ISCHEMIC CEREBRAL INFARCTION